Volume 26, Number 12—December 2020
CME ACTIVITY - Research
Tuberculosis among Children and Adolescents at HIV Treatment Centers in Sub-Saharan Africa
||Odds ratio (95% CI)
|Swaziland, Lesotho, Malawi, Tanzania-Mbeya, Tanzania-Mwanza, and Uganda||Referent|
|TB drug resistance|
|Not tested, multidrug resistance, not detected||Referent|
|Mono INH resistance
|Not advanced||0.59 (0.12–5.17)||0.2767|
|Each increasing WHO stage||2.18 (1.91–5.98)||0.001†|
*Variables included were sex, COE, site of TB, TB treatment category, TB drug resistance, age at ATT initiation, days in care at COE, ART regimen pre-ATT initiation, immune status, ART TB days, total ART drugs pre-ATT treatment, ART category, and World Health Organization stage. ART, antiretroviral therapy; ATT, anti-TB therapy; COE, Center of Excellence; TB, tuberculosis. †Significant result (p<0.05).
1These authors contributed equally to this article.